"Prothrombin Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
| Descriptor ID |
D011517
|
| MeSH Number(s) |
E01.370.225.625.115.610 E05.200.625.115.610 G09.188.680
|
| Concept/Terms |
Prothrombin Time- Prothrombin Time
- Prothrombin Times
- Time, Prothrombin
- Times, Prothrombin
|
Below are MeSH descriptors whose meaning is more general than "Prothrombin Time".
Below are MeSH descriptors whose meaning is more specific than "Prothrombin Time".
This graph shows the total number of publications written about "Prothrombin Time" by people in this website by year, and whether "Prothrombin Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prothrombin Time" by people in Profiles.
-
Diagnosis of human immunodeficiency virus associated disseminated intravascular coagulation. PLoS One. 2022; 17(1):e0262306.
-
Integrity of Uncapped Routine Coagulation Specimens Processed in an Automated Integrated Laboratory. Clin Lab. 2018 Jul 01; 64(7):1317-1321.
-
Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy. PLoS Negl Trop Dis. 2015; 9(8):e0003968.
-
Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption. Clin Toxicol (Phila). 2013 Aug; 51(7):527-31.
-
Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia. J Thromb Haemost. 2012 May; 10(5):773-80.
-
Circulating microparticles are elevated in carriers of factor V Leiden. Thromb Res. 2010 Sep; 126(3):250-3.
-
Anticoagulation in South Africa--a dangerous necessity. S Afr Med J. 2006 Aug; 96(8):694.
-
In vitro effects of thawing fresh-frozen plasma at various temperatures. Clin Appl Thromb Hemost. 2004 Apr; 10(2):143-8.
-
Audit of a walk-in oral anticoagulation clinic that uses near-patient testing. S Afr Med J. 2000 Jul; 90(7):706-7.
-
Haemostatic profile of the San (Bushmen) relocated to Schmidtsdrif. S Afr Med J. 1998 Jun; 88(6):715-6.